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Abstract
A population-based survey to provide informa-
tion on the prevalence of hepatitis viral infection 
and the pattern of risk factors was carried out in 
the urban population of all Brazilian state capi-
tals and the Federal District, between 2005 and 
2009. This paper describes the design and meth-
odology of the study which involved a popula-
tion aged 5 to 19 for hepatitis A and 10 to 69 for 
hepatitis B and C. Interviews and blood samples 
were obtained through household visits. The 
sample was selected using stratified multi-stage 
cluster sampling and was drawn with equal 
probability from each domain of study (region 
and age-group). Nationwide, 19,280 households 
and ~31,000 residents were selected. The study is 
large enough to detect prevalence of viral infec-
tion around 0.1% and risk factor assessments 
within each region. The methodology seems to be 
a viable way of differentiating between distinct 
epidemiological patterns of hepatitis A, B and C. 
These data will be of value for the evaluation of 
vaccination policies and for the design of control 
program strategies.
Morbidity Surveys; Prevalence; Hepatitis Viruses
Introduction
Population based serological studies of viral 
hepatitis have demonstrated the diversity of epi-
demiological patterns with regard to the risk of 
acquiring infection related to personal attributes, 
place and risk distribution over time. This pro-
vides crucial information for the national con-
trol program. In the USA, two national surveys of 
hepatitis B and C enabled the number of chroni-
cally infected individuals to be estimated and led 
to a greater understanding of the risk patterns 
associated with the use of illegal drugs and sexual 
behaviour over time 1,2,3,4,5.
Currently, the official Brazilian surveillance 
system requires compulsory notification of cas-
es of hepatitis A, B and C 6. Data from the passive 
notification-based surveillance system is not 
sufficiently reliable to estimate infection rates 
in the general population since a large number 
of viral infections are asymptomatic and the 
aetiology of notified symptomatic cases cannot 
always be confirmed. Thus, the epidemiologi-
cal patterns of HBV and HCV infections in Bra-
zil have been mainly assessed using data from 
blood donors, volunteers and special groups or 
from surveys conducted in restricted geographi-
cal areas 7,8,9,10,11. These previous studies sug-
gest wide variations in distribution of the dis-
ease from one Brazilian region to another, with 
high hepatitis B infection and co-circulation of 
Delta virus in the Amazon region 12. However, 
MÉTODOS   METHODS
Ximenes RAA et al.1694
Cad. Saúde Pública, Rio de Janeiro, 26(9):1693-1704, set, 2010
the prevalence of hepatitis in the general Brazil-
ian population is unknown and there is no in-
formation regarding the exact extent to which 
the frequency of infection and the pattern of risk 
factors vary from one Brazilian region to anoth-
er. Viral hepatitis is the most important cause 
of liver disease and hepatitis B and C have the 
potential to evolve into chronic hepatitis, cir-
rhosis and hepatocellular carcinoma, thus in-
creasing chronic liver disease mortality and the 
incidence of related hepatocellular carcinoma 
13,14. The hepatitis B vaccine has proved to be 
an important tool in the prevention of infection 
and the World Health Organization (WHO) rec-
ommends the inclusion of the hepatitis B vac-
cine in national immunization programs 15. In 
addition, targeting unvaccinated adults at risk 
of hepatitis B infection has also been proposed, 
in such a way as to cover anyone seeking pro-
tection from hepatitis B, even if no specific risk 
factor has been identified 16. Currently, Brazil-
ian health policy recommends HBV vaccination, 
which is provided free of charge to infants, chil-
dren and adolescents, besides the known risk 
groups 17. With regard to hepatitis A, strategies 
adopted to deliver vaccination vary according to 
the severity of the endemic, and universal vac-
cination in areas of low and intermediate ende-
micity has been advocated 18. In Brazil, the HAV 
vaccine is not universally recommended within 
the National Immunization Program and only a 
small proportion of the population has access to 
it. In a partial analysis of the ongoing Brazilian 
survey, hepatitis A infection was classified as an 
intermediate endemicity in the Northeast and 
Central-West regions of Brazil 19.
To evaluate the extent to which the popula-
tion may be infected is a particularly difficult task 
in a country like Brazil with a total population of 
approximately 190 million distributed in a huge 
territory of 8,511,965km2. On the other hand, in 
Brazil there has been a growing accumulation of 
experience with regard to the conduct of national 
surveys. For instance, the health supplement of 
the Pesquisa Nacional por Amostra de Domicílio 
– PNAD (National Survey by Household Sam-
pling), carried out by the Brazilian Institute of 
Geography and Statistics (IBGE), is possibly the 
most comprehensive health survey ever con-
ducted in the Brazilian population aged 14 and 
over, and other successful examples include the 
Pesquisa Nacional sobre Saúde e Nutrição – PNSN 
(National Survey on Health and Nutrition) and 
the Demographic and Health Survey (DHS) 20. 
It should be emphasized that an additional chal-
lenge is posed by serological surveys due to the 
logistics involved in blood collection, transporta-
tion, storage and testing.
Backed by successful experiences and weigh-
ing up the relevance of the information for the 
planning of control strategies, the Brazilian 
Ministry of Health has launched a nationwide 
household survey with a view to estimating the 
prevalence of hepatitis A, B and C and identify-
ing the most frequent HBV and HCV genotypes 
among residents of Brazilian state capitals and 
the Federal District. It also envisages to identify 
exposure through blood route exposure, sexual 
behaviour risk factors, use of alcohol and illegal 
drugs and socioeconomic variables accessed at 
individual, household and area levels. As a sec-
ondary objective, a plan has been drawn up to es-
timate the prevalence of hepatitis D in the North 
region of the country. This present paper reports 
the methods used for this first national survey of 
viral hepatitis infections ever conducted in Latin 
America.
Material and methods
Study design and population
This study is a population-based household 
survey by way of which the seroprevalences of 
the following serological markers for hepatitis 
A, B and C are currently being estimated: anti-
HAV IgG, HBsAg, anti-HBc IgG, anti-HBs, and 
anti-HCV. Potential biological, epidemiologi-
cal and socioeconomic risk factors are also be-
ing surveyed. The study population comprises 
all individuals aged 5 to 69, who are resident in 
private households in all the 26 Brazilian state 
capitals and in the Federal District during the 
survey period.
Sampling
• Domains of study
Brazil is composed of five different regions: 
the North, Northeast, Central-West, South and 
Southeast.
The Northeast region covers nine states 
(with respective capitals in parentheses): Bahia 
(Salvador), Sergipe (Aracaju), Alagoas (Maceió), 
Pernambuco (Recife), Paraíba (João Pessoa), Rio 
Grande do Norte (Natal), Ceará (Fortaleza), Piauí 
(Teresina), Maranhão (São Luís). The total popu-
lation of these capital cities for the 5-9, 10-19 and 
20-69 years age groups was 943,033, 2,054,539 
and 6,210,495, respectively.
The Central-West region comprises the states 
of Goiás (Goiânia), Mato Grosso do Sul (Campo 
Grande) and Mato Grosso (Cuiabá). The popu-
lation for those same age groups in the central-
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western capital cities was 397,740, 866,536 and 
2,619,378 inhabitants, respectively.
The Southeast region is comprised of the 
states of São Paulo (São Paulo), Rio de Janeiro 
(Rio de Janeiro), Espírito Santo (Vitória) and Mi-
nas Gerais (Belo Horizonte), with a population, in 
the same age groups, of 1,745,661, 3,803,187 and 
11,496,336, respectively.
The North region includes the states of Acre 
(Rio Branco), Amapá (Macapá), Roraima (Boa Vis-
ta), Rondônia (Porto Velho), Amazonas (Manaus), 
Pará (Belém) and Tocantins (Palmas), and the 
population in age groups 5-9, 10-19 and 20-69 
is 350,189, 762,940 and 2,306,227, respectively
The South region covers the states of Rio 
Grande do Sul (Porto Alegre), Santa Catarina (Flo-
rianópolis) and Paraná (Curitiba) with a popula-
tion for the target age groups of 305,652, 665,908 
and 2,012,918, respectively.
The Federal District, capital of Brazil (Brasília 
city), is located in the Central-West region and 
the populations for the above mentioned age 
groups were 182,537, 387,831 and 1,188,413, re-
spectively.
In view of the importance of estimating the 
prevalence of hepatitis A, B and C infection at 
national macro-regional level and for different 
age groups, the population resident in the state 
capitals and in the Federal District was divided 
into domains of study as outlined above.
• Sample size of individuals for each 
 domain of study
To estimate the prevalence of individuals with 
hepatitis A, B or C infection, the following for-
mula was used to calculate the sample size for 
each domain of study:
2
p
2
n



where,
n0: estimated sample size;
2
  = Px(1-P): variance of the study characteristic 
(hepatitis A, B or C) in the population;
2
p
: variance of the sampling distribution of p 
(prevalence of hepatitis A, B or C).
A confidence level of 95% was used. Tables 
1 and 2 present the other parameters used to 
calculate the estimated sample sizes for the do-
mains of study. In the expectation of a response 
rate of 80%, the sample sizes were adjusted using 
n = n0: 0.80.
The sample sizes were calculated on the ba-
sis of expected prevalence of seropositivity for 
HBsAg, for anti-HCV and for anti-HAV for each 
macro-region reported in previous studies 21,22. 
The prevalence of hepatitis A has been estimated, 
with defined precision, for each macro-region 
and for the Federal District, for the 5-9 year and 
10-19 year age-groups. Similarly, the prevalence 
of hepatitis B and hepatitis C was estimated, with 
defined precision, for each macro-region and for 
the Federal District for the 10-19 and 20-69 year 
age-groups.
The sampling procedure used in this study 
was cluster sampling. The observed precision 
does not therefore depend on the number of 
individuals in the selected sample alone, but 
also depends on the degree of homogeneity of 
the study variable within the clusters (Primary 
Sampling Units – PSUs), as well as on the average 
number of individuals selected in each PSU.
Table 1
Parameters used for the sample size calculations for each study domain, estimated sample size (n0) and estimated adjusted sample size (n) for the study of 
hepatitis A.
 Macro-region P 2
p
* n0 n
  5-9 years 10-19 years 5-9 years 10-19 years 5-9 years 10-19 years 5-9 years 10-19 years
 North 92.8 92.8 2.7842 2.7842 86 86 108 108
 Northeast 76.5 76.5 2.2952 2.2952 342 342 428 428
 Southeast 53.6 53.6 1.6082 1.6082 962 962 1,203 1,203
 South 51.2 51.2 1.5362 1.5362 1,059 1,059 1,324 1,324
 Central-West 76.5 76.5 2.2952 2.2952 342 342 428 428
 Federal District 76.5 76.5 2.2952 2.2952 342 342 428 428
* Corresponds to 3% of the proportion.
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Table 2
Parameters used for the sample size calculations for each domain of study, estimated sample size (n0) and estimated adjusted sample size (n) for the study of 
hepatitis B and C.
 Macro-region P 
2
p * n0 n
  10-19 years 20-69 years 10-19 years 20-69 years 10-19 years 20-69 years 10-19 years 20-69 years
 North 0.0212 0.0212 0.00422 0.00422 1,155 1,155 1,443 1,443
 North-East 0.0119 0.0119 0.00242 0.00242 2,075 2,075 2,594 2,594
 South-East 0.0143 0.0143 0.00292 0.00292 1,723 1,723 2,154 2,154
 South 0.0100 0.0100 0.00202 0.00202 2,475 2,475 3,094 3,094
 Central-West 0.0104 0.0104 0.00212 0.00212 2,378 2,378 2,973 2,973
 Federal District 0.0090 0.0090 0.00272 0.00272 1,124 1,124 1,405 1,405
* Corresponds to 20% of the proportion, with the exception of the Federal District which corresponds to 30%.
Figure 1
Strategy adopted to estimate the number of households to achieve the sample size of individuals – the case of the Northeast 
region, Brazil.
Northeast population in the
age-group of 5-9 (943,033)
Number of households in
Northeast (2,558,971)
Mean number of individuals by
household = 943,033 2,558,971
= 0.36852

Mean number of individuals by household
 =
Northeast samples of
individuals in the age-group
of 5-9 (428)
Mean number of individuals
by household (0.36852)
Number of households estimated in
Northeast = 428 0.36852 = 1,161
Number of households estimated
 =
Number of households estimated
in Northeast (1,161)
Number of households
in Northeast (2,558,971)
Sampling fractions for households
in Northeast = 1,161 2,558,971 =
0.000454

Sampling fractions for households
 =
Sampling fractions for households
in Northeast (0.000454)
Number of households
in Recife (376,022)
Number of households
estimated in Recife =
0.000454 x 376,022 = 171
Sampling fractions for households
x =
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• Sample size of households for each 
 domain of study
The study population in the geographical space 
was identified on the basis of the fact that the 
household was occupied at the time the sur-
vey was being carried out. A random sample of 
households was thus selected from each State 
capital and in the Federal District. All the indi-
viduals in the study age-groups resident in these 
selected households were eligible for inclusion in 
the samples.
To establish the number of households that 
should be visited in order to achieve the sample 
size of individuals, the mean number of individu-
als in each age-group per household was estimat-
ed. The largest sample size of households was 
that for the lower hepatitis prevalence and less 
frequent age-group in the population. Taking da-
ta from the Northeast, Figure 1 shows the strategy 
adopted to estimate the number of households 
to achieve the sample size of individuals.
However, if all individuals from the selected 
households were enrolled, the sample sizes for 
the other age-groups would greatly exceed the 
estimated samples, resulting in excessive cost. 
For this reason, sub-samples were drawn from 
the selected households. The results are present-
ed in Table 3.
The samples for each domain of study were 
allocated among the State capitals using a uni-
form sampling fraction (fi = ni / Ni, where fi: sam-
pling fraction for the domain i; ni: sample size for 
the domain i and Ni: population of the domain 
i), so that the sample size from each State capital 
was proportional to the population of that capi-
tal. Table 3 shows the sample sizes of households 
for the study of the hepatitis A, B and C for each 
Brazilian State capital and for the Federal Dis-
trict, the proportional distribution of individu-
als by State capital and Federal District expected 
to be obtained following the visit to the sampled 
households and the sampling fractions for each 
domain of study.
• Sampling procedures
The study sample was selected using stratified 
multi-stage cluster sampling based on the IBGE 
census data for the year 2000. The census tract is 
the smallest geographic unit available for which 
socioeconomic data on residents with similar 
economic characteristics are available and com-
prises approximately 300 households (approxi-
mately equal to 1,000 inhabitants). To improve 
the efficiency of sampling, the census tracts were, 
when necessary, either broken up or grouped to-
gether in such a way that the variation coefficient 
for their sizes should not exceed 10%. The PSUs 
thus represent a single census tract, a fraction of 
a census tract or a group of census tracts.
The PSUs were then ordered according to 
the number of years of schooling of the head of 
household to guarantee that all the socioeco-
nomic population groups were represented in 
the sample. This variable was selected because it 
is strongly correlated with income and provides 
more reliable information than the later.
In the first stage of sampling, a systematic 
sample was taken from this ordered list of PSUs 
with probability proportional to size in each State 
capital and in the Federal District. In the second 
stage, for each PSU drawn up in the first stage, 
block units were also selected with probability 
proportional to size. The third stage involved sys-
tematic sampling of households within each se-
lected block using a list of residential addresses. 
All current residents of the selected households 
within the study age-groups were included in the 
survey.
The samples were drawn with equal probabil-
ity from each domain of study in three stages. The 
overall sampling fraction applied to each state 
capital was, therefore, fhk = nhk / Nk, where fhk 
is the sampling fraction for macro-region k and 
age-group h, nhk is the sample size in number 
of households for the macro-region k and age-
group h and Nk is the total number of households 
in the macro-region k.
For each state capital, the first step in the full 
sampling procedure was to select the largest sam-
ple of households using the following equation:
iji
ij
i
i
k
M
c
M
bM
M
aM
f 

where,
fk: overall sampling fraction for the largest sample 
size in State capital k;
a: total number of PSUs to be selected in the first 
stage;
Mi: number of households in the PSU i;
b: number of secondary sampling units (SSU) to 
be drawn from each selected PSU;
Mij: number of households in SSU j of PSU i;
c: number of households to be drawn from each 
selected SSU.
To select the smaller samples in each State 
capital, a system of sub-samples were drawn 
from the initial sample using the following sam-
pling fraction:
l
khk
n
d
ff 
where,
fbk: overall sampling fraction for age-group h in 
State capital k;
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fk: overall sampling fraction for the largest sample 
in State capital k;
d: number of households to be drawn from the 
largest sample initially selected;
nl: number of households in the largest sample 
initially selected.
Serological markers and co-variables
For this study, the following serological markers 
were considered:
i) Hepatitis A: total antibodies for hepatitis A 
were tested using a commercial enzyme immu-
noassay kit; a positive test indicating current or 
past HAV infection (ever infected).
ii) Hepatitis B: antibodies for hepatitis B core 
antigen (anti-HBc) were tested by means of an 
enzyme-linked immunoassay. Positive results 
were considered HBV current or past infection 
(ever infected). Seropositive anti-HBc samples 
were also tested for hepatitis B surface antigen 
(HBsAg). When HBsAg-negative, these samples 
Table 3
Proportional distribution of the samples of individuals and households by state capitals and Federal District, Brazil,  according to age-groups for the study of 
hepatitis A, B and C.
 Region Hepatitis A Hepatitis B and C
 5-9 years a 10-19 years b 10-19 years c 20-69 years d
   Individual Household Individual Household Individual Household Individual Household
 North 112 285 108 130 1,490 1,738 1,443 575
  Rio Branco 7 19 7 9 97 121 97 40
  Macapá 8 20 8 9 108 122 108 40
  Manaus 40 100 40 46 538 618 538 205
  Belém 37 92 37 42 490 561 490 185
  Porto Velho 10 27 10 12 128 158 128 52
  Boa Vista 6 16 6 7 77 92 77 31
  Palmas 4 11 4 5 52 66 52 22
 Northeast 428 1,167 428 536 2,594 3,722 2,594 1,231
  Maceió 34 92 34 42 204 289 204 96
  Salvador 103 296 103 136 624 943 624 312
  Fortaleza 90 238 90 110 547 762 547 252
  São Luís 37 93 37 42 222 293 222 97
  João Pessoa 25 69 25 32 153 220 153 73
  Recife 60 171 60 78 364 544 364 180
  Teresina 30 77 30 35 182 246 182 81
  Natal 30 81 30 37 181 257 181 85
  Aracaju 19 52 19 24 118 169 118 56
 Southeast 1,203 3,792 1,203 1,741 2,154 3,116 2,154 1,031
  Vitória 19 59 19 27 33 48 33 16
  Belo Horizonte 143 433 143 199 256 356 256 118
  Rio de Janeiro 375 1,242 375 570 671 1,021 671 338
  São Paulo 666 2,058 666 945 1,193 1,691 1,193 559
 South 1,324 4,396 1,324 2,017 3,094 4,719 3,094 1,561
  Curitiba 639 2,041 639 937 1,493 2,189 1,493 724
  Florianópolis 138 450 138 206 322 483 322 160
  Porto Alegre 547 1,905 548 874 1,279 2,047 1,279 677
 Central-West 428 1,296 428 595 2,973 4,112 2,973 1,361
  Goiânia  209 649 209 297 1,450 2,060 1,450 682
  Cuiabá 92 263 92 121 643 835 643 276
  Campo Grande 127 384 127 177 880 1,217 880 403
  Federal District 428 1,236 428 566 1,405 1,860 1405 615
Note: Sampling fractions for households for hepatitis A, B and C according to the study age-groups: North (a 0.0003; b 0.0001; c 0.0019; d 0.0006), 
Northeast (a 0.0004; b 0.0002; c 0.0014; d 0.0005), Southeast (a 0.0002; b 0.0001; c 0.0013; d 0.0004), South (a 0.0043; b 0.0020; c 0.0039; d 0.0013), 
Central-West (a 0.0011; b 0.0005; c 0.0061; d 0.0020), Federal District (a 0.0022; b 0.0010; c 0.0034; d 0.0011).
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were tested for hepatitis B surface antibodies 
(HBsAb). Both tests were performed using the 
same technique. Borderline results were retested 
and indeterminate results were excluded from 
the analysis.
HBsAg positive samples were also tested for 
HBV-DNA and genotyped. Nested PCR was car-
ried out using the standard technique. Positive 
tests for antibodies for hepatitis B core antigen 
(anti-HBc) indicate current or past HBV infection.
iii) Hepatitis C: all the samples were screened 
using an automated ELISA. Samples with positi-
ve or indeterminate results were also tested using 
a further third-generation ELISA test. HCV-RNA 
detection using PCR was carried out on every 
sample with positive or indeterminate results. 
A reverse transcriptase-nested PCR was used to 
detect the HCV genome.
Information on co-variables at individual 
and household level was obtained using a ques-
tionnaire and area level variables retrieved from a 
subset of the IBGE census data (Table 4).
Laboratory methods
During the household visit, blood samples were 
collected, transported and stored according to 
standard procedures. Total antibodies for hepa-
titis A virus were detected using a commercial 
enzyme immunoassay kit (HAVAB EIA; Abbott 
Table 4
Variables studied at individual, household and area levels.
 Individual level Household level Area level
 Socio-demographic variables Home ownership Illiterate head of the household
  Gender Water supply Illiterate female head of the 
    household
  Age Pipe water inside the house 
  Literacy Regular water supply Mean level of schooling 
    of head of household 
    (years)
  Years of schooling Sewage disposal 
  Paid work last week Solid waste disposal 15-19 years illiterate individuals
 Reported vaccination status  Female head of the household
 Blood route transmission  Households with water supply
  Hospitalization  Households with waste collection
  Blood transfusion  Individuals per household
  Surgery  
  Dental treatment  
  Health care related job  
  Tattoo  
  Body piercing  
  Sharing of cutting objects  
 Sexual behaviour  
  Initiated sexual life  
  Homosexual partner  
  Another sexual partner besides current partner  
  Previous STD  
  Current partner had hepatitis  
  Previous sexual relation with known HBV carrier  
 Drug use-related factors  
  Ever use of smoked drugs  
  Ever use of inhalated drugs  
  Ever of sniffed drugs  
  Ever use of injected drugs  
  Previous use of glass syringe  
  Alcohol consumption  
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Laboratories, Abbott Park, U.S.A.) at central pub-
lic health laboratories. Laboratory tests were vali-
dated and quality control was monitored. Blood 
samples were tested for hepatitis B core antigen 
antibodies (anti-HBc) using enzyme-linked im-
munoassay – ELISA (Axsym, Abbott Laboratories) 
at central public health laboratories. Seropositive 
anti-HBc samples were tested for hepatitis B sur-
face antigen (HBsAg). Both tests were performed 
using the same technique (Axsym, Abbott Labo-
ratories). Borderline results were retested and 
indeterminate results were excluded from the 
analyses. All samples testing positive for HBV in 
the North region were also tested for the HDV 
marker (anti-HD IgG).
To study the prevalence of HCV infection in 
this population, all the samples were screened by 
an automated ELISA – Microparticle Enzime Im-
munoassay (MEIA) – (Axsym, Abbott Diagnostic, 
Germany). Samples with positive or indetermi-
nate results were also tested by another third-
generation ELISA test (Diasorin Saluggia Mark, 
Vercelli, Italy).
The HBV, HDV and HCV positive samples 
were genotyped.
HBsAg positive samples were also tested for 
HBV-DNA and genotyped. Nested PCR was car-
ried out as described by Kaneko et al. 23, with 
some modifications. The S region was amplified 
according to a standard technique 24 for iden-
tification of the HBV genotype. Sequencing re-
actions for characterization of viral strains were 
performed using PCR according to the method 
described elsewhere 25. Genotyping was ana-
lyzed by comparison of the sequences obtained 
with other known sequences from different HBV 
genotypes deposited in the GeneBank, using the 
Edit Seq and MegAlign softwares of the DNAstar 
package (Lasergene Inc., U.S.A.).
PCR HCV-RNA detection was carried out 
on every sample with positive or indeterminate 
results. A reverse transcriptase-nested PCR was 
used to amplify a fragment of the 5’UTR of the 
HCV genome. Any sample with a positive result 
in at least two out of three tests (PCR and both 
ELISA) was considered HCV positive.
Data collection: logistics
This survey was a collaborative undertaking in-
volving universities, State Health Secretaries and 
state-level referral laboratories. The research 
team responsible included a group of epidemi-
ologists, clinicians, laboratory staff and field-
workers from each setting, along with a regional 
and national coordinating group. The Brazilian 
Ministry of Health and Pan-American Health Or-
ganization (PAHO) supported the study. In order 
to assure community compliance, local lead-
ers were contacted and information about the 
survey was provided by local newspapers, radio, 
and television prior to commencing fieldwork in 
each locality.
Epidemiologists and clinicians were present 
at the three levels of coordination, while labora-
tory and fieldwork coordinators participated at 
the national and local levels. The training of the 
regional and local epidemiologist and clinical co-
ordinators, and the local laboratory coordinator 
was conducted by the national team.
The local teams also included interviewers, 
phlebotomists, data entry clerks and drivers.
The local epidemiology coordinator was re-
sponsible for standardizing and training the in-
terviewers in all procedures involved in data col-
lection and the clinician coordinator standard-
ized and trained the phlebotomists for blood col-
lection. The local clinician was also responsible 
for the delivery of the laboratory results to the 
participants, inviting those with positive results 
to visit the referral service for orientation and, 
when necessary, start treatment. These coordina-
tors were required to send weekly reports on the 
development of the study to the regional coordi-
nating group.
The local fieldwork coordinator organized the 
daily activities and distributed to the interviewers 
the household addresses, with their respective 
maps, stating the age-group to be interviewed in 
each household.
The interviewers together with the phleboto-
mists were instructed to visit the households and, 
after certifying that one or more of the residents 
fell into the required age-group, to explain the 
purposes of the study and obtain a signature in-
dicating informed consent.
In case of refusal, a second attempt was made 
by the fieldwork coordinator and, if the refusal 
was reaffirmed, the household was visited by the 
clinician. When no-one appeared to be at home 
in a household, at least two more visits were 
made on different occasions.
Fieldwork was carried out according to the 
agreed schedule, starting with the Northeast, 
Central-West and Federal District (2005-2006); 
followed by the South and Southeast regions 
(2007-2008), and, finally, the North region, to be 
concluded in 2009.
Quality assurance and quality control
Several efforts were made to standardize all pro-
cedures in the 26 State capitals and the Federal 
District. Manuals were written with instructions 
on how to conduct the fieldwork, interviewing, 
collecting blood samples, processing and storing 
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the blood collected and on sampling. Question-
naires were piloted before the final version was 
written and a sub-sample of households was re-
visited to check the questionnaire application. 
For the serological tests, the same commercial kit 
and the same machine were used in every State 
capital. Quality control at a referral laboratory 
was carried out for all laboratory results testing 
positive for hepatitis B and C, for a sample of 10% 
of the results testing negative and of those results 
which tested positive for hepatitis A.
Either the national and/or the regional co-
ordinators supervised the initial stages of the 
fieldwork in every State capital. The activities 
carried out in all localities were monitored by the 
national team, which received weekly reports on 
the fieldwork and laboratory activities.
Analysis guidelines
Data was double entered for validation and con-
sistency checking before statistical analysis was 
performed. The overall prevalence of seroposi-
tivity with a 95% confidence interval (95%CI) for 
hepatitis A, B and C infection was calculated (cor-
rected for the design effect) for each macro-region 
and the Federal District by age-group. For some 
analyses, macro-regions and/or age-groups were 
collapsed and, in these cases, weighting was ap-
plied, because different sampling fractions had 
been adopted for the study domains.
The age-specific distribution of the popula-
tion susceptible to each type of hepatitis infec-
tion was estimated using a simple catalytic model 
to estimate the force of infection.
The putative risk factors for each hepatitis in-
fection were initially investigated using bivariate 
analyses, separately for each age-group. To esti-
mate the magnitude of these associations, odds 
ratios with their respective 95%CI were used.
Random-effect multiple logistic regression 
models were designed to adjust for the effect of 
each variable on the others.
A multilevel model was proposed for assess-
ing risk at individual, household and area level 
using Generalized Linear and Latent Mixed Mod-
els (GLLAMM) on the Stata 9.2 software (Stata 
Corp., College Station, U.S.A.).
Ethical aspects
According to Resolution no. 196/96 of the Brazilian 
Ministry of Health, this project was submitted to 
Ethics Committees in all Brazilian regions. All in-
dividuals were informed regarding the objectives 
of the study and signed informed consent was 
requested from all participants. The results of 
the laboratory tests were returned confidentially 
to the participants. The negative results for all 
types of hepatitis or positive results for the anti-
HAV IgG and/or total anti-HBc and/or anti-HBs 
(which indicate immunity to hepatitis A and B, 
respectively) were posted by mail. The results for 
the positive cases of hepatitis B (positive HBsAg) 
and hepatitis C (positive anti-HCV) were deliv-
ered in person by the coordinating clinician. This 
clinician was responsible for performing a thor-
ough evaluation of these positive patients and, 
if recommended, they were referred for specific 
treatment at the relevant referral service in each 
State capital or the Federal District. HBV sero-
negative individuals were referred to the public 
health services for vaccination.
Strengths and weaknesses of the study
Interpretations of the results of epidemiological 
studies should be considered in light of the role 
of chance, i.e., sampling variation, and the pos-
sibility of selection or information bias and con-
founding factors.
The target population consisted of individu-
als aged from five to sixty-nine years, resident in 
private households in all Brazilian State capitals 
and in the Federal District during the survey pe-
riod. The study sample was randomly selected 
and adequate parameters were used to estimate 
its size. For the analysis, corrections were made 
for the design effect. The results can be extrapo-
lated for the all the State capitals and the Federal 
District taken as a whole.
Most of the capital cities (19 out of 26) includ-
ed in the study belong to Metropolitan Regions or 
to special Integrated Development Regions that 
include other municipalities. The latter may have 
poorer social and economic standards, which 
may in turn influence the occurrence of viral hep-
atitis. Therefore, our findings may not reflect the 
situation of the metropolitan regions and should 
only be taken to apply to the capital cities.
Selection bias was minimized by the follow-
ing strategies:
i) The sampling framework used for selecting 
census tracts and households was provided by 
the IBGE, which is the national institute respon-
sible for the Brazilian census;
ii) To avoid refusal to participate in the study, 
information on the survey was provided through 
the mass media, especially on local radio and 
television. Rigorous training of the local survey 
teams also facilitated their interaction with the 
study population;
iii) Comparability of infected and non-infected 
individuals was assured as they originated from 
the same population.
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Information bias may occur when there is an 
error in classifying the individuals, but its con-
sequences are different, depending on whether 
they occur independently – non-differential or 
not-differential – in the two axes of classification 
(exposure and outcome) of the individuals 26.
Information bias was minimized as follows:
i) At the time of the interview, neither the inter-
viewers nor the interviewees knew the results of 
the laboratory tests, as blood samples had not yet 
been collected. In addition, the laboratory tests 
were performed using standardized techniques 
and the laboratory personnel did not have access 
to the questionnaires. There was thus no way in 
which the serologic results could influence the 
application of the questionnaires or vice versa, 
making the possibility of a differential classifica-
tion error very low. Whereas a differential classi-
fication error may lead to overestimation or un-
derestimation of an effect, a non-differential er-
ror poses a less significant threat to validity, since 
bias occurs in a predictable direction, namely, 
in the direction of the null hypothesis. It is thus 
possible that the associations found in this study 
have been underestimated 26,27,28. Special care 
was taken to avoid possible bias introduced by 
the interviewer. Rigorous training was conducted 
in each State capital and a pilot of the question-
naire was applied in three capitals situated in 
different regions of the country (Recife, Manaus 
and Porto Alegre). Another potential limitation 
inherent in any household survey, such as this, is 
the possibility of underreporting or incorrect an-
swers being given to sensitive questions, includ-
ing those relating to current or former illegal drug 
use and sexual behaviour. For these reasons, risk 
assessment for HBV and HCV infections related 
to exposure to these should be interpreted with 
caution;
ii) The codification of the questionnaires was 
performed after the interview, by the local coor-
dinators;
iii) With regard to the errors inherent in the labo-
ratory procedures, it should be stressed that the 
commercial kits from just one manufacturer with 
a high degree of sensitivity and specificity were 
used. The same model of machinery was used in 
all State capitals. In addition, quality control was 
carried out at a referral laboratory for all positive 
laboratory results for hepatitis B and C and in a 
sample of 10% of those testing negative and of 
those positive for hepatitis A.
Finally, since this is a cross-sectional study, 
temporal ambiguity and survival bias may occur.
Cross-sectional studies are usually explained 
as different from follow-up and case-control de-
signs but they can be understood as the case-con-
trol analogue of the general population follow-up 
study, the cases being a prevalence series of indi-
viduals with the disease and the controls being 
the remainder of the study population 26. Odds 
ratios are often used in the statistical analysis of 
binary outcomes, even when the disease is not 
rare. In cross-sectional studies, when the disease 
is rare, the estimates obtained with the odds ratio 
are similar to those that would be obtained with 
the prevalence rate. When the disease is common 
the value of the odds ratio is numerically larger 
than the prevalence rate, but it is still a good esti-
mate of the odds ratio of the population.
So far as the possibility of distortion of the 
measures of association by confounding vari-
ables was concerned, all variables were adjusted 
for age. A multivariate analysis was conducted at 
different levels (individual, household and cen-
sus tract) and, in some instances, a multilevel 
analysis was carried out.
Conclusion
The approach used is a viable way of conducting 
surveys in countries where regular census data is 
collected. The proposed methodology is feasibly 
capable of differentiating various epidemiologi-
cal patterns of hepatitis A, B and C. It provides 
population-based information on the prevalence 
of behavioural and environmental exposure, as 
well as of viral markers. The methodology adopt-
ed is suitable to be adapted to large epidemio-
logical surveys with different goals.
Information provided by estimates of hepatitis 
A prevalence may prove useful base-line data for 
monitoring interventions regarding water supply 
and sewage disposal in different localities. In ad-
dition, the data are suitable for conducting cost-
benefit studies for the implementation of HAV 
immunization. With regard to hepatitis B and C, it 
is possible to estimate the number of individuals 
who will require special and complex means of 
diagnosis and medical care (biopsies, surgeries, 
transplants, cancer treatment, and antiviral and 
immunological therapy) to be provided by the 
Unified National Health System. The availability 
of such data may contribute to the identification 
of priority groups for HBV and HCV screening. It 
also enables the health authorities to follow-up 
asymptomatic individuals identified outside the 
health care system.
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Resumo
Um inquérito de base populacional foi conduzido na 
população urbana de todas as capitais e do Distrito 
Federal no Brasil para fornecer informações sobre a 
prevalência de hepatites virais e fatores de risco, entre 
2005 e 2009. Este artigo descreve o delineamento e a 
metodologia do estudo que envolveu a população com 
idade entre 5 e 19 anos para hepatite A e 10 a 69 anos 
para hepatite B e C. As entrevistas e amostras de san-
gue foram obtidas através de visitas domiciliares e a 
amostra selecionada a partir de uma amostragem es-
tratificada em múltiplos estágios (por conglomerado) 
com igual probabilidade para cada domínio de estu-
do (região e faixa etária). Nacionalmente, 19.280 re-
sidências e ~31.000 indivíduos foram selecionados. O 
tamanho da amostra foi suficiente para detectar uma 
prevalência em torno de 0,1% e para avaliar os fatores 
de risco por região. A metodologia apresentou-se viável 
para distinguir entre diferentes padrões epidemiológi-
cos da hepatite A, B e C. Estes dados serão de valia para 
a avaliação das políticas de vacinação e para o dese-
nho de estratégias de controle.
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